Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides

被引:20
作者
Aaltonen, K.
Ahlin, C.
Amini, R-M
Salonen, L.
Fjallskog, M.-L.
Heikkila, P.
Nevanlinna, H.
Blomqvist, C.
机构
[1] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00290 Helsinki, Finland
[2] Univ Orebro, Cent Hosp, Dept Gen Oncol, SE-70185 Orebro, Sweden
[3] Univ Uppsala Hosp, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
[4] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, FIN-00029 Helsinki, Finland
[5] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden
[6] Univ Helsinki, Cent Hosp, Dept Pathol, FIN-00014 Helsinki, Finland
关键词
breast cancer; cyclin A; tissue microarray;
D O I
10.1038/sj.bjc.6603147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin A has in some studies been associated with poor breast cancer survival, although all studies have not confirmed this. Its prognostic significance in breast cancer needs evaluation in larger studies. Tissue microarray (TMA) technique allows a simultaneous analysis of large amount of tumours on a single microscopic slide. This makes a rapid screening of molecular markers in large amount of tumours possible. Because only a small tissue sample of each tumour is punched on an array, the question has arisen about the representativeness of TMA when studying markers that are expressed in only a small proportion of cells. For this reason, we wanted to compare cyclin A expression on TMA and on traditional large sections. Two breast cancer TMAs were constructed of 200 breast tumours diagnosed between 1997-1998. TMA slides and traditional large section slides of these 200 tumours were stained with cyclin A antibody and analysed by two independent readers. The reproducibility of the two readers' results was good or even very good, with kappa values 0.71-0.87. The agreement of TMA and large section results was good with kappa value 0.62-0.75. Cyclin A overexpression was significantly (P < 0.001) associated with oestrogen receptor and progesterone receptor negativity and high grade both on TMA and large sections. Cyclin A overexpression was significantly associated with poor metastasis-free survival both on TMA and large sections. The relative risks for metastasis were similar on TMA and large sections. This study suggests that TMA technique could be useful to study histological correlations and prognostic significance of cyclin A on breast cancer on a large scale.
引用
收藏
页码:1697 / 1702
页数:6
相关论文
共 38 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]  
Altman D.G., 1991, Practical Statistics for Medical Research, DOI [10.1002/sim.4780101015, DOI 10.1002/SIM.4780101015]
[3]   Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time [J].
Bukholm, IR ;
Husdal, A ;
Nesland, JM ;
Langerod, A ;
Bukholm, G .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (02) :199-206
[4]   Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas [J].
Bukholm, IRK ;
Bukholm, G ;
Holm, R ;
Nesland, JM .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (05) :368-373
[5]   Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas [J].
Bukholm, IRK ;
Bukholm, G ;
Nesland, JM .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (02) :283-287
[6]   Validation of tissue microarray technology in breast carcinoma [J].
Camp, RL ;
Charette, LA ;
Rimm, DL .
LABORATORY INVESTIGATION, 2000, 80 (12) :1943-1949
[7]   Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? [J].
Colozza, M ;
Azambuja, E ;
Cardoso, F ;
Sotiriou, C ;
Larsimont, D ;
Piccart, MJ .
ANNALS OF ONCOLOGY, 2005, 16 (11) :1723-1739
[8]   Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families [J].
Eerola, H ;
Heikkilä, P ;
Tamminen, A ;
Aittomäki, K ;
Blomqvist, C ;
Nevanlinna, H .
BREAST CANCER RESEARCH, 2005, 7 (01) :R93-R100
[9]  
Elston C W, 2002, Histopathology, V41, P154
[10]  
Gillett CE, 2000, J PATHOL, V192, P549